United States · 
What does Life Science Angels invest in?
Life Science Angels invests most often at Series A and Series B (68% of the rounds on record), in sectors such as Therapeutics, Ivd and Lifesciences.
Life Science Angels highlights
- 01
25 rounds on record
- 02
Mostly Series A and Series B: 68% of its rounds
- 03
3 exits from the portfolio
What they do
#1 Angel Group - CB Insights, 2014From their own website
- Type
- Angel network (from a list, unverified)
- Cheque size
- $250K – $750K as they say
- Stages
- SeedSeries ASeries BGrowth
- Sectors
- TherapeuticsIvdLifesciences
- Based in
- Sunnyvale, United States
- Cold pitches
- Accepted
The record
Every round we can evidence, newest first25 appearances
- 2023
1 round
- Aug
- 2019
1 round
- Jan
- 2015
1 round
- Aug
- 2014
4 rounds
- Sept
- Aug
- Jun
- May
- 2013
1 round
- Aug
- 2012
1 round
- Jun
- 2011
3 rounds
- Sept
- May
- Jan
- 2010
3 rounds
- Apr
- Jan
- Jan
- 2009
2 rounds
- Nov
- Nov
- 2008
2 rounds
- Mar
- Mar
- 2007
5 rounds
- Nov
- Nov
- Oct
- Jul
- Mar
- 2006
1 round
- Aug
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
We hold 28 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
Exits from the portfolio
Companies it backed that were later bought or listed3 in all
AllylixBought by EvolvaUndisclosedNov 2014
VasoNovaBought by TeleflexUndisclosedJan 2011
ZogenixListedUndisclosedNov 2010
An exit counts when it came after the firm's first round in the company. From historical deal records.